• Subscribe
  • Newsfeed
  • About
  • Jobs
AI Search
Announce News

Verbund X Ventures: Investment Portfolio & Startup News

Verbund X Ventures

To add a bio or update investment portfolio click update information.

Investment Portfolio

    Gridcog secures £7m in a Series A round led by ABB for its energy flexibility modelling platformGridcog secures £7m in a Series A round led by ABB for its energy flexibility modelling platform
    Gridcog
    14 Jul 2026

    Gridcog secures £7m in a Series A round led by ABB for its energy flexibility modelling platform

    Gridcog is a platform for modelling energy flexibility, used by project developers, investors, utilities and energy majors to simulate storage, flexible load, renewable and hybrid energy assets across the full project lifecycle. The platform helps energy professionals make investment and design decisions on project type, location and market by modelling generation, storage, grid constraints, network tariffs and market participation.

    Greenpixie raises £4.7m pre-Series A round led by VERBUND X Ventures to help decarbonise cloud and AI infrastructure usageGreenpixie raises £4.7m pre-Series A round led by VERBUND X Ventures to help decarbonise cloud and AI infrastructure usage
    Greenpixie
    18 May 2026

    Greenpixie raises £4.7m pre-Series A round led by VERBUND X Ventures to help decarbonise cloud and AI infrastructure usage

    Greenpixie provides sustainability intelligence for cloud and AI infrastructure. Its technology helps enterprise IT teams reduce wasted cloud usage, optimise AI model use and choose lower-carbon regions.

Verbund X Ventures
    • Energy
    • Enterprise
  • 2(12 months)
  • verbundx.com/en/ventures

More venture news

  • Zya lands a £12m Series A round led by Astanor to turn sugar in food into prebiotic fibre
    Zya
    16 Nov 2026

    Zya lands a £12m Series A round led by Astanor to turn sugar in food into prebiotic fibre

    Series AHealth
  • Oyster Therapeutics secures a £45m Series A round from CE-Ventures to develop an oral drug for neurodegenerative diseases
    Oyster Therapeutics
    13 Nov 2026

    Oyster Therapeutics secures a £45m Series A round from CE-Ventures to develop an oral drug for neurodegenerative diseases

    Series ALife Sciences
  • UFORCE secures a £530m Series A round led by Valor Equity Partners and UK National Wealth Fund to build uncrewed defence platforms
    UFORCE
    12 Nov 2026

    UFORCE secures a £530m Series A round led by Valor Equity Partners and UK National Wealth Fund to build uncrewed defence platforms

    Series ADefence

Sign-up to our newsletter

The UK Weekly email covers every VC round from last week, firms that are hiring, and much more

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn

Announce

  • Share your story

General

  • Read the latest
  • About Soapbox

Information not up to date?

Get in touch

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn